Familial mediterranean fever medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[help:How to Edit a Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
Attacks are self-limiting, and require [[analgesia]] and [[non-steroidal anti-inflammatory drug]]s (such as [[diclofenac]]).<ref name=Livneh/> | Attacks are self-limiting, and require [[analgesia]] and [[non-steroidal anti-inflammatory drug]]s (such as [[diclofenac]]).<ref name=Livneh/> | ||
Revision as of 18:51, 6 March 2013
|
Familial Mediterranean Fever Microchapters |
|
Differentiating Familial Mediterranean Fever from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Familial mediterranean fever medical therapy On the Web |
|
American Roentgen Ray Society Images of Familial mediterranean fever medical therapy |
|
Directions to Hospitals Treating Familial mediterranean fever |
|
Risk calculators and risk factors for Familial mediterranean fever medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Attacks are self-limiting, and require analgesia and non-steroidal anti-inflammatory drugs (such as diclofenac).[1]
Since the 1970s, colchicine, a drug otherwise mainly used in gout, has been shown to decrease attack frequency in FMF patients. The exact way in which colchicine suppresses attacks is unclear. While this agent is not without side-effects (such as abdominal pain and muscle pains), it may markedly improve quality of life in patients. The dosage is typically 1-2 mg a day. Development of amyloidosis is delayed with colchicine treatment. Interferon is being studied as a therapeutic modality.[1]